Automate Your Wheel Strategy on DOCS
With Tiblio's Option Bot, you can configure your own wheel strategy including DOCS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol DOCS
- Rev/Share 3.0282
- Book/Share 5.7476
- PB 10.2217
- Debt/Equity 0.0114
- CurrentRatio 6.9669
- ROIC 0.1737
- MktCap 11010760206.0
- FreeCF/Share 1.4241
- PFCF 41.0471
- PE 49.5834
- Debt/Assets 0.0098
- DivYield 0
- ROE 0.2238
- Rating A-
- Score 4
- Recommendation Buy
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 4
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | DOCS | Evercore ISI | In-line | Outperform | -- | $70 | July 9, 2025 |
| Upgrade | DOCS | BTIG Research | Neutral | Buy | -- | $80 | June 2, 2025 |
| Upgrade | DOCS | Leerink Partners | Market Perform | Outperform | $60 | $90 | Feb. 7, 2025 |
| Upgrade | DOCS | Piper Sandler | Neutral | Overweight | $31 | $78 | Feb. 7, 2025 |
| Initiation | DOCS | Stephens | -- | Equal Weight | -- | $55 | Dec. 20, 2024 |
| Initiation | DOCS | Mizuho | -- | Neutral | -- | $55 | Dec. 4, 2024 |
| Upgrade | DOCS | Barclays | Equal Weight | Overweight | $35 | $52 | Oct. 15, 2024 |
News
Doximity Momentum, Big Money Support Stays Strong
DOCS
Published: February 14, 2025 by: FXEmpire
Sentiment: Positive
Published: February 14, 2025 by: FXEmpire
Sentiment: Positive
Shares of Doximity, Inc. (DOCS) jump on business growth, investor inflows.
Read More
Doximity (DOCS) is an Incredible Growth Stock: 3 Reasons Why
DOCS
Published: February 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Published: February 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Doximity (DOCS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
Why Doximity (DOCS) Might be Well Poised for a Surge
DOCS
Published: February 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Published: February 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Doximity (DOCS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Read More
Doximity (DOCS) is a Great Momentum Stock: Should You Buy?
DOCS
Published: February 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Published: February 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Does Doximity (DOCS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Read More
About Doximity, Inc. (DOCS)
- IPO Date 2021-06-24
- Website https://www.doximity.com
- Industry Medical - Healthcare Information Services
- CEO Jeffrey A. Tangney
- Employees 827
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.